About Us

Ottawa based, Marcan Pharmaceuticals Inc. is a rapidly growing pharmaceutical company actively engaged in the development, marketing, sales and distribution of both brand and generic pharmaceutical products for the Canadian market. 

Marcan currently manufactures and distributes a variety of medications covering a wide array of therapeutic categories through numerous dosage forms.

In 2015, Marcan was acquired by
Emcure Pharmaceuticals LTD., a vertically integrated global manufacturer and R&D leader.  Through optimizing this partnership, Marcan continues to focus on the development and growth of its Canadian portfolio.

Marcan's Timeline

2005

IPG- Product development arm of our company founded

2008

Launched 1st Rx product for licensing

2009

Launched 1st first-to-market generic.

2011

Established Marcan Pharmaceuticals Inc. the sales, marketing and distribution arm of the company

2015

Marcan/IPG acquired by Emcure Pharmaceuticals

2017

Launched first alternative dosage product in the form of an injectable.

2018

Continued development of hospital focused portfolio.

Our Mission

Our mission is to be a leader in supplying innovative, high quality and cost-effective medications to Canadians.

We work closely with organizations engaged in generics related research and development (R&D) as well as decision-makers at grassroots like pharmacy chains to sell quality generics in Canada.

link arrow
Explore more about latest Products

Health Products Stewardship Association

Don't throw them out, visit www.healthsteward.ca